Agile Bioanalytical Services CRO
/
northeastbiolab
Follow Us On LinkedIn
Request Quote
✕
Expertise
All Expertise
Mass Spec (LC-MS)
Mass Spec Services
HPLC Testing Services
ELISA Service
MSD Assay
Luminex Multiplex
Flow Cytometry
ddPCR Service, qPCR
Western Blot, In Cell
Services
All Services
Pharmacokinetics (PK)
ADME Service
Tox Study
Dose Formulation
Bioequivalence Study
PK PD Analysis
DMPK Service
ADA Assay, NAb Assay
Multiplex Cytokine Assay
Biomarker Assay
Biomarker Assay Menu
Cell-Based Assay
Cytotoxicity Assay
Mechanism of Action
Biochemical Assay
Bioanalytical Assay
Solutions
All Solutions
Clinical CRO
Central Lab Services
PBMC Services
GLP Laboratory
Bioanalysis
Non-GLP Testing
Preclinical CRO
Method Dev, Validation
Method Validation
Method Development
Method Transfer
Analytical Testing
Discovery Screening
Analytical Quantitation
Cosmetic Testing
About Us
About Us
Overview
Leadership
Facility & Equipment
Quality & Compliance
Therapeutic Areas
Why Us?
Values
Process
Partners
Careers
Sr. Scientist – Cell Based Assay
Associate Scientist, Central Laboratory Services
Business Development Associate
Sr. Scientist, LC-MS/MS Bioanalysis – Hamden, CT, USA
Sr. Scientist, ELISA Immunoassay Bioanalysis – Hamden, CT, USA
GLP Quality Assurance Manager
Sr. Scientist - Pharmacokinetics (PK)
Content Manager, Scientific and Regulatory Writing
Resources
Learning Center
Blog
Case Study
Video Brochures
News & Events
Testimonials
Contact Us
Request Quote
Contact Us
Home
FDA Nonclinical Safety Evaluation of Drugs and Biologics (2020)
Nonclinical Safety Evaluation of the Immunotoxic Potential of Drugs and Biologics Guidance for Industry (2020)
Retrieved From
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/nonclinical-safety-evaluation-immunotoxic-potential-drugs-and-biologics-guidance-industry